Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Reardon

Showing results (521-530 of 558) with videos related to

Pageof 56
Sort By:
JACC. Cardiovascular Interventions|May 20, 2017
1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical BioprosthesesG Michael Deeb, Stanley J Chetcuti, Michael J Reardon, et al.
Circulation. Cardiovascular Interventions|October 18, 2024
Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis PatientsThomas Modine, Didier Tchétché, Nicolas M Van Mieghem, et al.
Lancet (London, England)|June 29, 2020
Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trialRaj R Makkar, Wen Cheng, Ron Waksman, et al.
JAMA|January 4, 2018
Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical TrialTed E Feldman, Michael J Reardon, Vivek Rajagopal, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 18, 2025
Five-Year Outcomes of the Early-Generation Intrepid Transapical Transcatheter Mitral Valve Replacement SystemGilbert H L Tang, Vivek Rajagopal, Paul Sorajja, et al.
JACC. Cardiovascular Interventions|October 21, 2019
Novel Multiphase Assessment for Predicting Left Ventricular Outflow Tract Obstruction Before Transcatheter Mitral Valve ReplacementChristopher U Meduri, Michael J Reardon, D Scott Lim, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 26, 2014
Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgeryMichael J Reardon, David H Adams, Joseph S Coselli, et al.
JAMA Cardiology|December 14, 2022
Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High RiskDaniel O'Hair, Steven J Yakubov, Kendra J Grubb, et al.
Journal of the American College of Cardiology|June 10, 2015
2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve ReplacementMichael J Reardon, David H Adams, Neal S Kleiman, et al.
Journal of the American College of Cardiology|March 4, 2022
2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk PatientsJohn K Forrest, G Michael Deeb, Steven J Yakubov, et al.
Pageof 56

Showing results (521-530 of 558) with videos related to

Sort By:
Pageof 56
JACC. Cardiovascular Interventions|May 20, 2017
1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical BioprosthesesG Michael Deeb, Stanley J Chetcuti, Michael J Reardon, et al.
Circulation. Cardiovascular Interventions|October 18, 2024
Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis PatientsThomas Modine, Didier Tchétché, Nicolas M Van Mieghem, et al.
Lancet (London, England)|June 29, 2020
Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trialRaj R Makkar, Wen Cheng, Ron Waksman, et al.
JAMA|January 4, 2018
Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical TrialTed E Feldman, Michael J Reardon, Vivek Rajagopal, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 18, 2025
Five-Year Outcomes of the Early-Generation Intrepid Transapical Transcatheter Mitral Valve Replacement SystemGilbert H L Tang, Vivek Rajagopal, Paul Sorajja, et al.
JACC. Cardiovascular Interventions|October 21, 2019
Novel Multiphase Assessment for Predicting Left Ventricular Outflow Tract Obstruction Before Transcatheter Mitral Valve ReplacementChristopher U Meduri, Michael J Reardon, D Scott Lim, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 26, 2014
Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgeryMichael J Reardon, David H Adams, Joseph S Coselli, et al.
JAMA Cardiology|December 14, 2022
Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High RiskDaniel O'Hair, Steven J Yakubov, Kendra J Grubb, et al.
Journal of the American College of Cardiology|June 10, 2015
2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve ReplacementMichael J Reardon, David H Adams, Neal S Kleiman, et al.
Journal of the American College of Cardiology|March 4, 2022
2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk PatientsJohn K Forrest, G Michael Deeb, Steven J Yakubov, et al.
Pageof 56